Prospective exosome‐focused translational research for afatinib study of non‐small cell lung cancer patients expressing EGFR (EXTRA study)

Patients with EGFR‐mutated non‐small cell lung cancer (NSCLC) exhibit resistance to EGFR‐tyrosine kinase inhibitors (TKIs) within 9–14 months of therapy. Recently, EGFR‐mutated NSCLC has demonstrated the potential for heterogeneity; therefore, the manner of clonal heterogeneity may impact the durati...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Thorac Cancer
Main Authors: Okuma, Yusuke, Morikawa, Kei, Tanaka, Hisashi, Yokoyama, Takuma, Itani, Hidetoshi, Horiuchi, Kazuya, Nakagawa, Hideyuki, Takahashi, Nobumasa, Bessho, Akihiro, Soejima, Kenzo, Kishi, Kazuma, Togashi, Akira, Kanai, Yae, Ueda, Koji, Horimoto, Katsuhisa, Matsutani, Noriyuki, Seki, Nobuhiko
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley & Sons Australia, Ltd 2018
Assuntos:
Study Protocol
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6360199/
https://ncbi.nlm.nih.gov/pubmed/30536780
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12923
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares